New Times,
New Thinking.

Keir Starmer opens up clear lead over Boris Johnson in public approval

Those who approve of the Labour leader's performance include more than one in four Conservative voters.

By Patrick Maguire

Keir Starmer is enjoying considerably greater public approval than either Boris Johnson or the government, new polling for the New Statesman has found.

The new Labour leader enjoys a net approval rating of 21 per cent – 20 per cent more than the 1 per cent net approval recorded for Boris Johnson in this month’s New Statesman poll by Redfield and Wilton Strategies.

Those who approve of Starmer’s performance include more than one in four – 26 per cent – of 2019 Conservative voters, 31 per cent of whom disapprove of his performance.

Among Labour voters, meanwhile, he enjoys a towering net approval rating of 54 per cent, with 61 per cent approving and only seven per cent disapproving of his performance.

When asked about the pandemic specifically, a third of voters say Starmer is doing a good job, while 16 per cent say he is doing a bad job. Twice as many voters – 32 per cent – say Labour has not responded well to the pandemic, with the same number taking the opposite view.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

The findings also suggest that a large proportion of voters have yet to make their mind up on Starmer. Some 35 per cent neither approve nor disapprove of his performance as leader, while 7 per cent say they do not know whether they approve or disapprove.

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines